Systemic lupus erythematosus–driven accelerated atherosclerosis: the immune–metabolic–vascular axis and therapeutic implications

• by Meiwei Jiang, FengQi Zhang, MinZhe Ren, ZhiYu Li, ZhiJun Xie, Jing Sun

• June 10, 2026

A Qualitative Analysis of Patient Perspectives and Preferences in Lupus Management to Guide Lupus Guidelines Development

• by Shivani Garg, Izzy Hartel, Lisa R. Sammaritano, Anca Askanase, Bonnie L. Bermas, Maria Dall'Era, Alí Duarte-García, Victoria P. Werth, Brad Rovin, Reem A. Mustafa, Amy S. Turner, Bené Williams, Brian L. Ung, Hiya Bhavsar, Monique C. Gore-Massy, Nahirannette Pulido, Natacha Guerrero, Natalie M. Smith, Wambui Machua, Linda T. Hiraki, Mary Beth Son

• July 1, 2026

Correction: The association between systemic lupus erythematosus and cognitive impairment or dementia: a meta-analysis

• by Yanan Wang, Sai Jiang, Yicong Liu, Hejing Pan, Lin Huang, Chengping Wen, Xuanlin Li, Zhijun Xie

• June 17, 2026

In Vivo CAR T: A New Route to Treating Autoimmune Disease

How targeted in vivo CAR T delivery could pave the way for autoimmune disease treatments

• by Ying K. Tam, Sean Semple

• July 13, 2026

• 7 min